Association of CD57+ Natural Killer Cells with Better Overall Survival in DLBCL Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Malignant tumor cells may evoke the innate and adaptive immune systems. Various immune cells are involved in this immune reaction, and tumor infiltrating lymphocytes, macrophages, natural killer (NK) cells are associated with patient prognosis for solid tumors. Methods: Seventy-eight patients who were diagnosed with diffuse large B cell lymphoma (DLBCL) between 2001 and 2009 were selected. CD57+ NK cells, CD68+ tumor associated macrophages (TAMs), and CD4+ and CD8+ T cells were evaluated in tissue sections using immunohistochemical staining and compared with clinical parameters including age, gender, performance status, clinical stage, serum lactic dehydrogenase level, number of extranodal sites, international prognostic index score, chemotherapy response, and survival. Results: Patients with high numbers of CD57+ NK cells had a significantly higher overall survival rate than patients with low numbers of CD57+ NK cells. However, no significant difference was observed between the number of CD57+ NK cells and other prognostic parameters. The number of CD68+ TAMs and CD4+ or CD8+ T cells was not significantly correlated with prognostic factors in patients with DLBCL. Conclusions: An evaluation of tumor infiltrating CD57+ NK cells is recommended as a prognostic indicator in patients with DLBCL.
Abstract
Background: Malignant tumor cells may evoke the innate and adaptive immune systems. Various immune cells are involved in this immune reaction, and tumor infiltrating lymphocytes, macrophages, natural killer (NK) cells are associated with patient prognosis for solid tumors. Methods: Seventy-eight patients who were diagnosed with diffuse large B cell lymphoma (DLBCL) between 2001 and 2009 were selected. CD57+ NK cells, CD68+ tumor associated macrophages (TAMs), and CD4+ and CD8+ T cells were evaluated in tissue sections using immunohistochemical staining and compared with clinical parameters including age, gender, performance status, clinical stage, serum lactic dehydrogenase level, number of extranodal sites, international prognostic index score, chemotherapy response, and survival. Results: Patients with high numbers of CD57+ NK cells had a significantly higher overall survival rate than patients with low numbers of CD57+ NK cells. However, no significant difference was observed between the number of CD57+ NK cells and other prognostic parameters. The number of CD68+ TAMs and CD4+ or CD8+ T cells was not significantly correlated with prognostic factors in patients with DLBCL. Conclusions: An evaluation of tumor infiltrating CD57+ NK cells is recommended as a prognostic indicator in patients with DLBCL.
참고문헌 (24)
- Rosenwald A, "The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma", N Engl J Med, 346, pp.1937~1947 (2002)
- Ziepert M, "Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era", J Clin Oncol, 28, pp.2373~2380 (2010)
- Xu Y, "Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study", Br J Haematol, 112, pp.945~949 (2001)
- Hasselblom S, "Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis", Pathol Int, 58, pp.529~532 (2008)
- Steidl C, "Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma", N Engl J Med, 362, pp.875~885 (2010)
- Wahlin BE, "A unifying microenvironment model in follicular lymphoma. Outcome is predicted by programmed death-1: positive, regulatory, cytotoxic, and helper T cells and macrophages", Clin Cancer Res, 16, pp.637~650 (2010)
- Qiu H, "The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer", Hepatogastroenterology, 56, pp.1310~1315 (2009)
- Hyakudomi M, "Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma", Ann Surg Oncol, 15, pp.1775~1782 (2008)
- Dirkx AE, "Monocyte", macrophage infiltration in tumors: modulators of angiogenesis, 2006, pp.80, 1183~1196
- Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed", pp.439~ (2008), International Agency for Research on Cancer
- Hans CP, "Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray", Blood, 103, pp.275~282 (2004)
- Cheson BD, "Revised response criteria for malignant lymphoma", J Clin Oncol, 25, pp.579~586 (2007)
- Balkwill F, "Cancer and inflammation: implications for pharmacology and therapeutics", Clin Pharmacol Ther, 87, pp.401~406 (2010)
- Wallace ME, "The role of natural killer cells in tumor control: effectors and regulators of adaptive immunity", Springer Semin Immunopathol, 27, pp.49~64 (2005)
- Woan K, "Potential therapeutic role of natural killer cells in cancer", Expert Opin Biol Ther, 7, pp.17~29 (2007)
- Dewan MZ, "Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells", Cancer Sci, 97, pp.1381~1387 (2006)
- Alvaro-Naranjo T, "Tumor-infiltrating cells as a prognostic factor in Hodgkin’s lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients", Leuk Lymphoma, 46, pp.1581~1591 (2005)
- Perez SA, "A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival", Blood, 106, pp.158~166 (2005)
- Screpanti V, "A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells", J Immunol, 167, pp.2068~2073 (2001)
- Mantovani A, "The origin and function of tumor-associated macrophages", Immunol Today, 13, pp.265~270 (1992)
- Clark WH Jr, "The histogenesis and biologic behavior of primary human malignant melanomas of the skin", Cancer Res, 29, pp.705~727 (1969)
- Mihm MC Jr, "Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response", Lab Invest, 74, pp.43~47 (1996)
- Ansell SM, "Cd4+ T-cell immune response to large B-cell non-Hodgkin’s lymphoma predicts patient outcome", J Clin Oncol, 19, pp.720~726 (2001)
- Hishii M, "Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes", Clin Exp Immunol, 116, pp.388~394 (1999)